Physician profile
Alan Micklin
NPI 1477582518
$538.43
in general payments reported to CMS, 2019-2025
16 companies · $83.86 in 2025
The $83.86 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.54 · 2020: $101 · 2021: $155 · 2022: $11.71 · 2023: $27.94 · 2024: $76.19 · 2025: $83.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $100.07 | 2021 | |
| Novartis Pharmaceuticals Corporation | $73.92 | 2019-2025 | |
| Boston Scientific Corporation | $43.71 | 2019-2021 | |
| Abiomed | $40.19 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $38.70 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $35.73 | 2023-2024 | Camzyos, Eliquis |
| Amgen INC. | $34.66 | 2020-2021 | |
| Esperion Therapeutics, INC. | $28.56 | 2021-2025 | Nexletol |
| Kestra Medical Technology Services, INC. | $24.52 | 2025 | Assure Wcd |
| Pfizer INC. | $24.25 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.42 | 2019 | |
| Amarin Pharma, INC. | $14.97 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.96 | 2023 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $13.99 | 2020 | |
| Siemens Medical Solutions USA, INC. | $13.53 | 2025 | Syngo Dynamics, Syngo.Via |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $13.25 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Micklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.